Skip to content

Insulet Corp

PODD· NasdaqCore metricsCIK 1145197

Surgical & medical instruments & apparatus143 peers

Close
Oct 26, 2026
Market cap
$10.35B
69.35M shares
Filings
1,044
$842.00M
Q3 2026+30.7% FY25 yoy
$141.10M
Q3 2026−40.9% FY25 yoy
$189.80M
Q3 2026+53.4% FY25 yoy
$211.80M
Q3 2026derived+23.7% FY25 yoy
$2.03
Q3 2026−39.8% FY25 yoy
$584.40M
Q3 2026−24.9% FY25 yoy
$10.35B
24.1×
3.2×
6.6×
2.51%
—

Twelve months to Sep 30, 2026 · derived

Price

$149.2654.19%$176.54past year
Oct 26, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.71BFY 2025
$2.71B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$2,708,100,000reported
FY 20242024-12-31$2,071,600,000reported
FY 20232023-12-31$1,697,100,000reported
FY 20222022-12-31$1,055,400,000 revisedreported
FY 20212021-12-31$1,040,600,000 revisedreported
FY 20202020-12-31$904,400,000reported
FY 20192019-12-31$738,200,000reported
FY 20182018-12-31$563,800,000reported
FY 20172017-12-31$463,800,000reported
FY 20162016-12-31$366,989,000reported
FY 20152015-12-31$263,893,000 revisedreported
FY 20142014-12-31$231,321,000 revisedreported

Capital returns

Dividends and buybacks · FY2023 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$59.60M$59.60M—70.40M sh+0.2%15.8%
FY2024—$0.00$0.00—70.23M sh+0.4%0.0%
FY2023—$0.00$0.00—69.93M sh+0.6%0.0%

Segments

Revenue by Geography, FY2020 to FY2025FY2020UNITED STATES · FY2020 · $596.40MInternational · FY2020 · $308.00MFY2021UNITED STATES · FY2021 · $738.90MInternational · FY2021 · $359.90MFY2022UNITED STATES · FY2022 · $942.30MInternational · FY2022 · $363.00MFY2023UNITED STATES · FY2023 · $1.29BInternational · FY2023 · $410.10MFY2024UNITED STATES · FY2024 · $1.55BInternational · FY2024 · $523.40MFY2025UNITED STATES · FY2025 · $1.95BInternational · FY2025 · $754.30M
LineFY2025ShareChange
UNITED STATES$1.95B72%+26.2%
International$754.30M28%+44.1%
Total$2.71B

From the 10-K filed Feb 18, 2026PODD

Surgical & medical instruments & apparatus

Insulet Corp is the 13th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Insulet Corp · CIK 1145197 · Engraved from SEC EDGAR